NCT06773182

Brief Summary

In this study, we are trying to learn how certain diets affect people with inflammatory bowel disease (IBD). We want to understand what makes it hard or easy for them to stick to different eating plans, like intermittent fasting, the Mediterranean diet, and the Low FODMAP diet. By finding out how these diets help with symptoms and which ones are easier to follow, we hope to improve the quality of life for people with IBD.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
7mo left

Started Apr 2025

Geographic Reach
1 country

3 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress65%
Apr 2025Jan 2027

First Submitted

Initial submission to the registry

January 8, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

January 14, 2025

Completed
3 months until next milestone

Study Start

First participant enrolled

April 1, 2025

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2026

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2027

Expected
Last Updated

June 26, 2025

Status Verified

June 1, 2025

Enrollment Period

1 year

First QC Date

January 8, 2025

Last Update Submit

June 23, 2025

Conditions

Keywords

IBDLow FODMAP DietMediterranean dietIntermittent fastingUlcerative colitisCrohn's disease

Outcome Measures

Primary Outcomes (1)

  • To identify IBD's top three patients' barriers to access and follow the nutritional intervention.

    The outcome will be assessed through semi-structured one-on-one interviews conducted at the end of the study. Interviews will last approximately 40 minutes to 1 hour and will follow a structured interview guide with open-ended questions, designed to explore participants' experiences, perceptions, and challenges in accessing and adhering to the nutritional intervention. Interviews will be audio-recorded and transcribed verbatim. Data will be analyzed using thematic analysis informed by interpretive description methodology, to identify key personal and systemic barriers. NVivo software (QSR International) will be used to facilitate qualitative coding and analysis.

    From enrollment to the end of the study and at 5 weeks

Secondary Outcomes (2)

  • To identify specific sociodemographic criteria that may act as a deterrent or facilitator in the ability to generate honest qualitative data through questionnaires and an individual interview.

    From enrollment to the end of the study and at 5 weeks

  • To identify adherence to each food intervention through the use of an app (RxFood) and different questionnaires.

    From enrollment to the end of the study and at 5 weeks

Study Arms (3)

Intermittent Fasting

EXPERIMENTAL

Participants will be assigned to follow an intermittent fasting protocol.

Mediterranean Diet

EXPERIMENTAL

Participants will be assigned to follow a Mediterranean diet.

Low FODMAP Diet

EXPERIMENTAL

Participants will be assigned to follow a Low FODMAP Diet.

Other: Low FODMAP Diet Intervention

Interventions

A 14:10 intermittent fasting regimen, where participants fast for 14 hours and consume all meals within a 10-hour eating window daily.

A diet emphasizing whole grains, fruits, vegetables, olive oil, lean proteins, and minimizing processed foods.

A diet limiting fermentable oligosaccharides, disaccharides, monosaccharides, and polyols to manage gastrointestinal symptoms.

Low FODMAP Diet

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults (18+ years) diagnosed with ulcerative colitis or Crohn's disease.
  • Having willingness to use their personal smartphone to access the app
  • Able to understand the indication by the registered dietitian.
  • Able to provide informed consent.
  • Willingness to attempt intervention diet and commit to study procedures.

You may not qualify if:

  • Pregnant women.
  • Currently being treated for eating disorders, schizophrenia, psychosis, or other acute mental disorders.
  • Currently being treated for chemotherapy.
  • Diabetes
  • Advance chronic kidney disease
  • Short bowl syndrome

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

2F Digestive Diseases Clinic - Hamilton Health Science

Hamilton, Ontario, L8N 3Z5, Canada

RECRUITING

McMaster University

Hamilton, Ontario, L8S 4K1, Canada

NOT YET RECRUITING

McMaster University

Hamilton, Ontario, L8S 4K1, Canada

NOT YET RECRUITING

MeSH Terms

Conditions

Inflammatory Bowel DiseasesColitis, UlcerativeCrohn DiseaseIntermittent Fasting

Condition Hierarchy (Ancestors)

GastroenteritisGastrointestinal DiseasesDigestive System DiseasesIntestinal DiseasesColitisColonic DiseasesFastingFeeding BehaviorBehavior

Central Study Contacts

Camila Pettinari, Bacherol

CONTACT

Vanina Noejovich, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This is a mixed-design, randomized, parallel-group trial with three independent arms. Participants will be randomly assigned to one of three dietary intervention groups: intermittent fasting, the Mediterranean diet, or the Low FODMAP diet. Each arm will operate independently, and participants will adhere exclusively to their assigned dietary intervention throughout the study duration. The design ensures that the effects of each diet are evaluated in isolation, allowing for a direct comparison of adherence rates, perceived benefits, and impacts on IBD symptom management across the groups.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

January 8, 2025

First Posted

January 14, 2025

Study Start

April 1, 2025

Primary Completion

April 1, 2026

Study Completion (Estimated)

January 1, 2027

Last Updated

June 26, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will share

Approach investigators to ask for anonymized dataset

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
Data will be available after data completion - estimated 1 year
Access Criteria
The research team who will evaluate the interventions of diet in IBD

Locations